Observation on the effect of H-uvulopalatopharyngoplasty for OSAHS
patients

doi:10.3760/cma.j.issn.1007-1245.2022.12.007

Abstract

Abstract: Objective　To investigate the efficacy of H-uvulopalatopharyngoplasty in patients with obstructive sleep apnea hypopnea syndrome (OSAHS). Methods　The clinical data of 108 patients with OSAHS admitted to Department of Otolaryngology, Dongguan Chang'an Hospital from January 2015 to January 2020 were retrospectively analyzed. All patients were divided into an experimental group and a control group according to the random number table, with 54 cases in each group. In the control group, there were 26 males and 28 females, aged (39.34±3.26) years; in the experimental group, there were 28 males and 26 females, aged (38.84±3.54) years. The control group underwent simple palatopharyngoplasty, and the experimental group underwent H-uvulopalatopharyngoplasty. Apnea hypopnea index (AHI), Epworth Sleepiness Scale (ESS), lowest blood oxygen saturation (LSaO₂), momentary expiratory flow at 75% (MEF75), forced expiratory volume in 1 second (FEV1), and peak expiratory flow rate (PEF) were compared between the two groups before surgery and 1, 3, and 6 months after surgery, and the clinical efficacies of the two groups were evaluated. Independent sample t test was used for the measurement data, and χ² test was used for the count data. Results　The AHI value of the experimental group were (18.36±1.89) times/h 1 month after surgery, (15.24±1.35) times/h 3 months after surgery, and (14.09±1.25) times/h 6 months after surgery, respectively, which were lower than those of the control group [(20.95±1.74) times/h, (18.63±1.42) times/h, and (16.34±1.08) times/h], the ESS scores were (7.24±1.56) points, (6.95±0.69) points, and (5.67±0.35) points, respectively, which were lower than those of the control group [(9.29±1.47) points, (8.33±0.72) points, and (8.01±0.54) points], with statistically significant differences (all P<0.05). The MEF75 index of the experimental group was (89.85±7.69)% 3 months after surgery and (96.34±8.44)% 6 months after surgery, which were higher than those of the control group [(84.29±7.30)% and (89.36±7.95)%], the FEV1 indexes were (95.30±7.41)% and (99.20±7.25)%, which were higher than those of the control group [(92.34±6.71)% and (94.24±6.03)%], the PEF indexes were (91.29±4.36)% and (95.37±5.88) %, which were higher than those of the control group [(87.63±5.01)% and (91.24±5.24)%], and the LSaO₂ indexes were (85.01±6.34)% and (89.01±7.42)%, which were higher than those of the control group [(80.63±5.96)% and (84.39±6.33)%], with statistically significant differences (all P<0.05). The total effective rate of the experimental group was 96.30% (52/54), which was significantly higher than 85.19% (46/54) of the control group, with a statistically significant difference (χ²=3.967, P=0.046). Conclusion　H-uvulopalatopharyngoplasty has better short-term and long-term efficacies in the treatment of OSAHS patients, which is of great significance for improving the quality of life in patients with OSAHS.

Key words: H-uvulopalatopharyngoplasty, OSAHS, Curative effect

摘要： 目的　探讨阻塞性睡眠呼吸暂停低通气综合征（OSAHS）患者应用改良悬雍垂腭咽成形术治疗的效果。方法　回顾性分析2015年1月至2020年1月东莞市长安医院耳鼻咽喉科收治的108例OSAHS患者临床资料，将患者以随机数字表法分为试验组和对照组，各54例。对照组男26例、女28例，年龄（39.34±3.26）岁，采取单纯腭咽成形术；试验组男28例、女26例，年龄（38.84±3.54）岁，采取改良悬雍垂腭咽成形术。比较两组患者术前及术后1个月、3个月、6个月呼吸暂停低通气指数（AHI）、Epworth嗜睡量表（ESS）、最低血氧饱和度（LSaO₂）、用力呼出75%肺活量时的瞬间呼气流量（MEF75）、第1秒用力呼吸容积（FEV1）、呼气峰流速（PEF）指标，评价两组患者临床疗效。计量资料采用独立样本t检验，计数资料采用χ²检验。结果　术后1个月、3个月、6个月，试验组AHI值分别为（18.36±1.89）次/h、（15.24±1.35）次/h、（14.09±1.25）次/h，均低于对照组（20.95±1.74）次/h、（18.63±1.42）次/h、（16.34±1.08）次/h，ESS评分分别为（7.24±1.56）分、（6.95±0.69）分、（5.67±0.35）分，均低于对照组（9.29±1.47）分、（8.33±0.72）分、（8.01±0.54）分，差异均有统计学意义（均P<0.05）。术后3个月、术后6个月，试验组MEF75指标为（89.85±7.69）%、（96.34±8.44）%，均高于对照组（84.29±7.30）%、（89.36±7.95）%，FEV1指标为（95.30±7.41）%、（99.20±7.25）%，均高于对照组（92.34±6.71）%、（94.24±6.03）%，PEF指标为（91.29±4.36）%、（95.37±5.88）%，均高于对照组（87.63±5.01）%、（91.24±5.24）%，LSaO₂指标为（85.01±6.34）%、（89.01±7.42）%，均高于对照组（80.63±5.96）%、（84.39±6.33）%，差异均有统计学意义（均P<0.05）。试验组总有效率为96.30%（52/54），显著优于对照组85.19%（46/54），差异有统计学意义（χ²=3.967，P=0.046）。结论　改良悬雍垂腭咽成形术治疗OSAHS患者近期及远期疗效更佳，对改善OSAHS患者的生活质量有重大意义。

关键词: 改良悬雍垂腭咽成形术, OSAHS, 疗效

Xu Zhenbin, Yang Xiaoxiong, Zhuang Yanyun, Xi Yanjun, Chen Peng, Wu Qi, Yuan Meirong, Ji Chulian. Observation on the effect of H-uvulopalatopharyngoplasty for OSAHS patients[J]. International Medicine and Health Guidance News, 2022, 28(12): 1656-1660.

许镇斌, 杨小雄, 庄燕云, 席艳君, 陈鹏, 巫琪, 袁美蓉, 纪楚莲. OSAHS患者应用改良悬雍垂腭咽成形术治疗的效果观察[J]. 国际医药卫生导报, 2022, 28(12): 1656-1660.

References

[1] Tsou YA, Chou EC, Shie DY, et al. Polysomnography and nocturia evaluations after uvulopalatopharyngoplasty for obstructive sleep apnea syndrome[J].J Clin Med,2020,9(10):3089. DOI:10.3390/jcm9103089.

[2] Hsu YS, Hsu WC, Ko JY, et al. Incidence of multilevel surgical procedures and readmissions in uvulopalatopharyngoplasty in Taiwan[J].JAMA Otolaryngol Head Neck Surg,2019,145(9):803-810. DOI:10.1001/jamaoto.2019.1656.

[3] 廖海石,林云雁,冯剑华,等. 鼻腔扩容术联合改良悬雍垂腭咽成形术治疗中重度OSAHS的有效性分析[J]. 中国医药科学,2020,10(11):254-256. DOI:10.3969/j.issn.2095- 0616.2020.11.071.

[4] Baradaranfar MH, Edalatkhah M, Dadgarnia MH, et al. The effect of uvulopalatopharyngoplasty with tonsillectomy in patients with obstructive sleep apnea[J].Indian J Otolaryngol Head Neck Surg,2015,67(Suppl 1):29-33. DOI:10.1007/s12070-014-0735-1.

[5] 董冰婉,张俊波,肖水芳. Friedman分型联合术后早期睡眠脉氧监测对悬雍垂腭咽成形术疗效的预测价值[J]. 北京大学学报(医学版),2020,52(2):281-284. DOI:10.19723/j.issn.1671-167X.2020.02.014.

[6] Cho JH, Suh JD, Han KD, et al. Uvulopalatopharyngoplasty may reduce the incidence of dementia caused by obstructive sleep apnea: national insurance service survey 2007-2014[J].J Clin Sleep Med,2018,14(10):1749-1755. DOI:10.5664/jcsm.7388.

[7] 田秋实,初腾,逄明杰,等. 改良悬雍垂腭咽成形联合鼻腔扩容术对多平面阻塞OSAHS患者肺功能的影响[J]. 山东医药,2020,60(5):57-59. DOI:10.3969/j.issn.1002- 266X.2020.05.014.

[8] 来育斌,胡鹏刚,张昌明,等. 改良悬雍垂腭咽成形术同期联合鼻甲骨折外移治疗伴有鼻阻的OSAHS患者疗效分析[J]. 山西医药杂志,2020,49(8):999-1001. DOI:10.3969/j.issn.0253-9926.2020.08.029.

[9] 罗世逸,羊书勇,吴坡,等. 双颌前徙术配合颏成形术对OSAHS患者气道容积的影响[J]. 西南国防医药,2020,30(1):38-40. DOI:10.3969/j.issn.1004-0188.2020.01.014.

[10] 谭健,陈伟,崔前波,等. 围手术期综合干预在阻塞性睡眠呼吸暂停低通气综合征腭咽成形术中的应用[J]. 中华物理医学与康复杂志,2019,41(10):773-776. DOI:10.3760/cma.j.issn.0254-1424.2019.10.013.

[11] 刘坤. 持续正压通气对重度阻塞性睡眠呼吸暂停低通气综合征行悬雍垂腭咽成形术患者疗效及睡眠结构的影响[J]. 实用临床医药杂志,2019,23(16):54-57. DOI:10.7619/jcmp.201916015.

[12] 黎燕群,万程伟,陈妍,等.持续气道正压通气治疗对OSAHS患者肠道菌群的影响[J].现代医院,2020,20(10):1539-1541. DOI:10.3969/j.issn.1671-332X.2020.10.038.

[13] 杨森,黄定强,赵春蓉,等. 悬雍垂腭咽成形术在OSAHS治疗中的应用及患者血氧饱和度、鼾声指数与并发症发生情况[J]. 中国老年学杂志,2019,39(14):3458-3461. DOI:10.3969/j.issn.1005-9202.2019.14.037.

[14] 丹静静,陶树东,阎朝晖. 悬雍垂腭咽成形术对OSA H S患者咽喉反流的影响[J]. 听力学及言语疾病杂志,2020,28(1):53-56. DOI:10.3969/j.issn.1006-7299.2020.01.014.

[15] 路莉. 鼻腔扩容术联合腭咽成形术治疗阻塞性睡眠呼吸暂停低通道综合征的疗效评价[J]. 贵州医药,2019,43(4):582-584. DOI:10.3969/j.issn.1000-744X.2019.04.027.

[16] 陈曦,袁伟,李进让. 悬雍垂腭咽成形术联合等离子射频辅助舌减容术治疗OSAHS的疗效分析[J]. 中国耳鼻咽喉颅底外科杂志,2018,24(3):266-269. DOI:10.11798/j.issn.1007-1520.201803015.

[17] 刘志勇,张楠. 不同正颌术式治疗重度OSAHS患者的疗效观察[J]. 口腔颌面外科杂志,2018,28(3):152-156. DOI:10.3969/j.issn.1005-4979.2017.03.006.

[18] 赵亚会,戴嵩. 悬雍垂腭咽成形术对OSAHS患者免疫功能的影响[J]. 锦州医科大学学报,2019,40(1):63-65. DOI:10.13847/j.cnki.lnmu.2019.01.020.

[19] 张峰,姚红兵,杨大志,等. 不同手术方式治疗学龄前儿童OSAHS术前及术后免疫功能的比较[J]. 检验医学与临床,2019,16(3):312-315. DOI:10.3969/j.issn.1672-9455. 2019.03.008.

[20] 郑雪松,于兆祥,付文义. 成人阻塞性睡眠呼吸暂停低通气综合征患者行扁桃体切除术治疗疗效分析[J]. 中国地方病防治杂志,2018,33(6):665-666.

[21] 靳佳慧,黄淑新,梁玉莹,等. 腭咽平面前后径狭窄的OSAHS患者行悬雍垂软腭皮瓣术的疗效分析[J]. 临床耳鼻咽喉头颈外科杂志,2018,32(23):1817-1821. DOI:10.13201/j.issn.1001-1781.2018.23.012.

[22] Amali A, Motiee-Langroudi M, Saedi B, et al. A comparison of uvulopalatopharyngoplasty and modified radiofrequency tissue ablation in mild to moderate obstructive sleep apnea: a randomized clinical trial[J].J Clin Sleep Med,2017,13(9):1089-1096. DOI:10.5664/jcsm.6730.

[23] Nishimura Y, Fujii N, Yamamoto T, et al. Volumes of velopharyngeal and glossopharyngeal airway were not changed after uvulopalatopharyngoplasty: report of three cases[J].Case Rep Otolaryngol,2016,2016:9378428. DOI:10.1155/2016/9378428.

[24] 程蕾蕾,许凤,周光耀. 改良悬雍垂腭咽成形术围手术期手术风险分析[J]. 中国耳鼻咽喉头颈外科,2018,25(6):321-325. DOI:10.16066/j.1672-7002.2018.06.010.

[25] Stanley JJ, Shelgikar AV, Aronovich S, et al. Efficacy of oral appliance therapy in patients following uvulopalatopharyngoplasty failure[J].Laryngoscope Investig Otolaryngol,2019,4(2):269-273. DOI:10.1002/lio2.256.

[26] 庞伟. 改良悬雍垂腭咽成形术联合下鼻甲射频消融术对重度阻塞性睡眠呼吸暂停低通气综合征(OSAHS)患者ESS评分及安全性的影响[J]. 吉林医学,2021,42(4):940-942.

[27] 韩鹏飞,谷雷. 改良悬雍垂腭咽成形术对重度阻塞性睡眠呼吸暂停低通气综合征患者的疗效[J]. 河南医学研究,2021,30(9):1616-1618. DOI:10.3969/j.issn.1004- 437X.2021.09.029.

[28] Guo X, Zhao Y, Wang M, et al. The posterior pharyngeal wall thickness is associated with OSAHS in patients with acromegaly and correlates with IGF-1 levels[J].Endocrine,2018,61(3):526-532. DOI:10.1007/s12020-018-1631-3.

[29] Saffer F, Lubianca Neto JF, Rösing C, et al. Predictors of success in the treatment of obstructive sleep apnea syndrome with mandibular repositioning appliance: a systematic review[J].Int Arch Otorhinolaryngol,2015,19(1):80-85. DOI:10.1055/s-0034-1393957.

[30] 侯炜,许映龙,高天喜. 改良悬雍垂腭咽成形术联合鼻部同期手术对重度阻塞性睡眠呼吸暂停低通气综合征的疗效分析[J]. 川北医学院学报,2020,35(1):100-102,117. DOI:10.3969/j.issn.1005-3697.2020.01.026.

[31] 吕凯,袁琨,陈伟,等.悬雍垂腭咽成形术后阻塞性睡眠呼吸暂停综合征患者心率和血压与自主神经功能恢复的相关性分析[J].中国医师进修杂志,2021,44(3):208-214. DOI:10.3760/cma.j.cn115455-20191227-01093.

Observation on the effect of H-uvulopalatopharyngoplasty for OSAHS patients

OSAHS患者应用改良悬雍垂腭咽成形术治疗的效果观察

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 3

Recommended Articles

Metrics

[1]	Zhang Wenjun, Li Yueming, He Shiqi, Liang Shuhong, Liu Yingxue, Wu Yiling, Gong Yeqing. Effect of semiconductor laser combined with 30% supramolecular salicylic acid in treatment of acne curative and nursing experience [J]. International Medicine and Health Guidance News, 2022, 28(7): 1013-1016.
[2]	Qi Youtao, Wang Dongmei, Bai Yuhuan, Kong Lingjia, Jing Changchun, Ji Bei. Apatinib combined with tegafur in treatment of patients with advanced gastric cancer and its influence on prognosis [J]. International Medicine and Health Guidance News, 2022, 28(13): 1815-1819.
[3]	Li Hongjun. Clinical effect and safety of pulmonary surfactant combined with NCPAP in the treatment of NRDS in different periods [J]. International Medicine and Health Guidance News, 2022, 28(10): 1414-1417.